In fatty liver mouse model and NAFLD patients, the expression of genes involved in hepatic mitochondrial beta-oxidation such as PPARα, PGC1α and CPT1a is elevated as expected (Kohjima et al., 2007; Liu et al., 2018; Pittala et al., 2019). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.